RA Capital Healthcare Fund LP
10% owner at FULC; Affiliate at ANTX; 10% Stockholder at CNTB, and 5 more
- Sold, on record
- $184M
- Dollars the filings state
- Form 4 sales
- 12
- Latest Dec 8, 2025
- Form 144 notices
- 5
- Proposed sales
- Companies
- 8
- Filed as an executive or holder
Companies
- FULCFulcrum Therapeutics, Inc.10% owner
- ANTXAN2 Therapeutics, Inc.Affiliate
- CNTBConnect Biopharma Holdings Ltd10% Stockholder
- scPharmaceuticals Inc.10% owner
- VSTMVerastem, Inc.10% owner
- ACHILLION PHARMACEUTICALS INCOther
- SGMOSANGAMO THERAPEUTICS, INCOther
- CRISCURIS INC10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- ACHILLION PHARMACEUTICALS INC5.8M shares
- SGMO4.4M shares
- FULC4.2M shares
- ANTX3.5M shares
- CRIS1.3M shares
- VSTM1.2M shares
- scPharmaceuticals Inc.150,057 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale scPharmaceuticals Inc.Plan not statedMar 15, 2021 2021
Sold 150,057 shares at $7.08 ($1.1M)
RA Capital Healthcare Fund LP, 10% owner
Sold 5.2% of holdings ($20.4M position)2.7M shares leftFirst sale on recordFiling
- 2 Form 144 notice CNTBNoticeNov 21, 2023 +981 days
Filed to sell 471,732 shares ($972k)
RA Capital Healthcare Fund LP, 10% Stockholder
No 10b5-1 planFirst sale on recordFiling
- 3 Form 144 notice CNTBNoticeNov 27, 2023 +6 days
Filed to sell 906,504 shares ($1.2M)
RA Capital Healthcare Fund LP, 10% Stockholder
No 10b5-1 planFirst sale on recordFiling
- 4 Form 144 notice CNTBNoticeDec 12, 2023 +15 days
Filed to sell 220,738 shares ($199k)
RA Capital Healthcare Fund LP, 10% Stockholder
No 10b5-1 planFirst sale on recordFiling
- 5 Form 144 notice CNTBNoticeDec 18, 2023 +6 days
Filed to sell 1.8M shares ($1.7M)
RA Capital Healthcare Fund LP, 10% Stockholder
No 10b5-1 planFirst sale on recordFiling
- 6 Form 4 sale ANTXUnusualAug 9, 2024 +235 days
Sold 3.5M shares at $1.08 ($3.8M)
RA Capital Healthcare Fund LP, 10% owner
No 10b5-1 planSold 92.1% of holdings ($4.1M position)300,853 shares leftFirst sale on recordFiling
- 7 Form 144 notice ANTXNoticeAug 15, 2024 +6 days
Filed to sell 1.7M shares ($1.7M)
RA Capital Healthcare Fund LP, Affiliate
No 10b5-1 planFiling
- 8 Form 4 sale FULCUnusualDec 8, 2025 +480 days
Sold 4.2M shares at $13.98 ($58.4M)
RA Capital Healthcare Fund LP, 10% owner
No 10b5-1 planSold 40.8% of holdings ($143M position)6.1M shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (17)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 8, 2025 | Dec 10, 2025 | FULC | 10% owner | Form 4 sale | 4.2M | $58.4M | 40.8% | Unusual | SEC |
| Aug 15, 2024 | Aug 15, 2024 | ANTX | Affiliate | Form 144 notice | 1.7M | $1.7M | Notice | SEC | |
| Aug 9, 2024 | Aug 13, 2024 | ANTX | 10% owner | Form 4 sale | 3.5M | $3.8M | 92.1% | Unusual | SEC |
| Dec 18, 2023 | Dec 18, 2023 | CNTB | 10% Stockholder | Form 144 notice | 1.8M | $1.7M | Notice | SEC | |
| Dec 12, 2023 | Dec 12, 2023 | CNTB | 10% Stockholder | Form 144 notice | 220,738 | $199k | Notice | SEC | |
| Nov 27, 2023 | Nov 27, 2023 | CNTB | 10% Stockholder | Form 144 notice | 906,504 | $1.2M | Notice | SEC | |
| Nov 21, 2023 | Nov 21, 2023 | CNTB | 10% Stockholder | Form 144 notice | 471,732 | $972k | Notice | SEC | |
| Mar 15, 2021 | Mar 16, 2021 | scPharmaceuticals Inc. | 10% owner | Form 4 sale | 150,057 | $1.1M | 5.2% | Plan not stated | SEC |
| Jun 25, 2020 | Jun 29, 2020 | VSTM | 10% owner | Form 4 sale | 1.2M | $2.2M | 6.7% | Plan not stated | SEC |
| Sep 30, 2014 | Oct 1, 2014 | ACHILLION PHARMACEUTICALS INC | Other | Form 4 sale | 1.3M | $13.6M | 16.6% | Plan not stated | SEC |
| Aug 18, 2014 | Aug 19, 2014 | ACHILLION PHARMACEUTICALS INC | 10% owner | Form 4 sale | 4.2M | $40.3M | 18.8% | Plan not stated | SEC |
| Aug 1, 2014 | Feb 18, 2015 | SGMO | Other | Form 4 sale | 1M | $14.9M | 36.2% | Unusual | SEC |
| Jun 5, 2014 | Feb 18, 2015 | SGMO | Other | Form 4 sale | 2M | $26.7M | 41.8% | Unusual | SEC |
| Apr 1, 2014 | Feb 18, 2015 | SGMO | Other | Form 4 sale | 536,771 | $11.3M | 11.7% | Plan not stated | SEC |
| Sep 12, 2013 | Jan 20, 2015 | ACHILLION PHARMACEUTICALS INC | 10% owner | Form 4 sale | 200,080 | $1.4M | 4.0% | Plan not stated | SEC |
| Jul 25, 2013 | Feb 18, 2015 | SGMO | Other | Form 4 sale | 817,444 | $8M | 20.8% | Plan not stated | SEC |
| Apr 15, 2008 | Apr 17, 2008 | CRIS | 10% owner | Form 4 sale | 1.3M | $1.8M | 17.2% | Plan not stated | SEC |